Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?

Diabetic macular oedema (DMO) is a common ocular problem among patients with diabetic retinopathy, which is sight-threatening and leads to blindness. The gold standard treatment for DMO had been focal/grid laser photocoagulation that achieved stabilisation of disease progression. However, newer phar...

Full description

Bibliographic Details
Main Authors: Kuan Hao Yee, Srinivasan Sanjay
Format: Article
Language:English
Published: European Medical Journal 2017-10-01
Series:European Medical Journal Diabetes
Subjects:
efficacy
read-2
bolt
da vinci
drcr
protocol t
diabetic retinopathy
bevacizumab
aflibercept
pegaptanib
laser
ranibizumab
diabetic macular oedema
anti-vascular endothelial growth factor
Online Access:https://www.emjreviews.com/diabetes/article/anti-vascular-endothelial-growth-factor-therapy-in-diabetic-macular-oedema-is-it-effective/

Internet

https://www.emjreviews.com/diabetes/article/anti-vascular-endothelial-growth-factor-therapy-in-diabetic-macular-oedema-is-it-effective/

Similar Items